These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 890495

  • 21. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
    Hossain MA, Weiner N.
    J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Innervation of the substantia nigra.
    Misgeld U.
    Cell Tissue Res; 2004 Oct; 318(1):107-14. PubMed ID: 15338269
    [Abstract] [Full Text] [Related]

  • 27. Gabaergic regulation of nigrostriatal neurons: coupling of benzodiazepine and GABA receptors.
    Wood PL, Etienne P, Lal S, Nair NP.
    Prog Neuropsychopharmacol Biol Psychiatry; 1982 Oct; 6(4-6):471-4. PubMed ID: 6298891
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Regulation of nigro-striatal dopaminergic neurotransmission in the rat.
    Dray A, Fowler LJ, Oakley NR, Simmonds MA, Tanner T.
    Neuropharmacology; 1977 Oct; 16(7-8):511-8. PubMed ID: 199852
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Dopaminergic--GABA-ergic interaction in the nigrostriatal system.
    Koltai MZ, György L.
    Acta Physiol Acad Sci Hung; 1981 Oct; 58(3):225-33. PubMed ID: 7348023
    [Abstract] [Full Text] [Related]

  • 36. Evidence for a role of nigral gamma-aminobutyric acid and substance P in the haloperidol-induced activation of striatal tyrosine hydroxylase.
    Gale K, Costa E, Toffano G, Hong JS, Guidotti A.
    J Pharmacol Exp Ther; 1978 Jul; 206(1):29-37. PubMed ID: 26799
    [No Abstract] [Full Text] [Related]

  • 37. Activity-dependent changes in substantia nigra gamma-aminobutyric acid.
    Swift RM, Hoffmann PC, Heller A.
    Brain Res; 1978 Nov 03; 156(1):181-6. PubMed ID: 308835
    [No Abstract] [Full Text] [Related]

  • 38. [Physiology and pharmacology of extrapyramidal tract].
    Yoshida M, Mizuno Y.
    Nihon Rinsho; 1975 Oct 03; 33(10):2964-77. PubMed ID: 128646
    [No Abstract] [Full Text] [Related]

  • 39. [Stereotyped behavior and the nigro-strio-nigral system].
    Arushanian EB.
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1985 Oct 03; 35(5):819-32. PubMed ID: 2866641
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.